Date | Title | Description | Source |
02.04.2024 | Экономический анализ: как генеративный ИИ меняет производите... | На связи Алексей Мартынов и Денис Ларионов, мы продолжаем делиться актуальной аналитикой о генератив... | habr.com/r... |
06.03.2024 | Latest Updates of Viva Biotech's Portfolio Companies | HONG KONG, March 6, 2024 /PRNewswire/ -- Even with the ever-changing situation, technological innova... | en.prnasia... |
28.02.2024 | Absci Announces $75M Public Offering to Fuel AI Drug Creatio... | What You Should Know:
– Absci Corporation (Nasdaq: ABSI), a company utilizing generative AI for drug... | hitconsult... |
20.12.2023 | Absci, PrecisionLife Partner to Develop AI-Enabled Drug Pipe... | What You Should Know:
– Absci, a generative AI drug creation company, and PrecisionLife, a pioneer i... | hitconsult... |
04.12.2023 | Absci and AstraZeneca Sign $247M Partnership for AI-Powered ... | What You Should Know:
– Absci Corporation (ABSI), a pioneer in using generative AI to discover antib... | hitconsult... |
10.07.2023 | How AI is changing the way scientists engineer drugs, biosen... | RF Diffusion, a deep learning tool, was prompted to generate a new protein (orange) that binds to th... | geekwire.c... |
30.06.2023 | Recent Digital Health Hires & Board Appointments | Theralink Technologies, Inc. appoints Faith Zaslavsky as its new Chief Executive Officer. Ms. Zaslav... | hitconsult... |
28.02.2023 | Absci Takes Its Generative AI Antibody Design Platform To Eu... | Christine Lemke, SVP of Portfolio & Growth Strategy, Andreas Busch, Chief Innovation Officer, an... | forbes.com... |
10.02.2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Auto... | This is our AI Daily Roundup . We are covering the top updates from around the world. The updates wi... | aithority.... |
09.02.2023 | Absci Deepens Scientific Advisory Board to Accelerate Genera... | In silico antibody design expert Dr. Victor Greiff, synthetic biology pioneer Dr. Timothy Lu, and tr... | aithority.... |
10.01.2023 | Absci First to Create and Validate De Novo Antibodies with Z... | Creating antibodies in silico with generative AI represents a major industry breakthrough on the pat... | aithority.... |
10.01.2023 | How generative AI and E. coli are speeding up new drug disco... | Check out all the on-demand sessions from the Intelligent Security Summit here.
For many, hearing th... | venturebea... |
10.08.2022 | Absci lays off staff as it looks to reorganize amid stoc... | Vancouver, WA-based Absci appeared to be riding high after netting greater amounts of fundin... | endpts.com... |
22.07.2021 | How Sean McClain founded Absci at just 22 — and now leads a ... | Absci CEO and founder Sean McClain rings the closing bell on the NASDAQ on Thursday with his team as... | geekwire.c... |
30.06.2021 | Vancouver, Wash. biotech company Absci files to go public | Absci CEO and founder Sean McClain. (Absci Photo)
Absci, a Vancouver, Wash.-based company developing... | geekwire.c... |
14.06.2021 | AbSci Announces Acquisition of Target Discovery Company Toti... | | prnewswire... |
23.03.2021 | Biotech startup AbSci raises $125M for ‘Protein Printing’ te... | AbSci CEO and founder Sean McClain. (AbSci Photo)
New funding: Vancouver, Wash.-based biotech compan... | geekwire.c... |
23.03.2021 | AbSci Announces Completion of $125 Million Crossover Financi... | | prnewswire... |
23.03.2021 | AbSci announces completion of $125 million crossover financi... | - | colventure... |
05.03.2021 | Biotech startup AbSci lands investment from Merck’s VC arm t... | Vancouver, Wash.-based biotech company AbSci raised an undisclosed amount of funding from pharmaceut... | geekwire.c... |
24.02.2021 | AbSci Receives Strategic Investment From Merck Global Health... | AbSci, a Vancouver, Wash.-based synthetic biology company that unifies biologic drug discovery and d... | finsmes.co... |
22.02.2021 | AbSci Announces Strategic Investment by Merck Global Health ... | | prnewswire... |
12.01.2021 | AbSci Announces Acquisition of Deep Learning Company Denoviu... | | prnewswire... |
12.01.2021 | AbSci acquires AI startup Denovium to boost synthetic biolog... | AbSci CEO and Founder Sean McClain. (AbSci Photo)
AbSci has acquired Denovium, a 6-person bootstrapp... | geekwire.c... |
11.11.2020 | AbSci Announces Recent Additions to Board of Directors | | prnewswire... |
20.10.2020 | Synthetic biology startup AbSci raises $65M to expand ‘Prote... | AbSci CEO and Founder Sean McClain. (AbSci Photo)
Vancouver, Wash.-based biotech company AbSci raise... | geekwire.c... |
20.10.2020 | Months after striking a deal with Sanofi, AbSci nails its... | Months after nailing down a $10.4 million Series D and a partnership with French pharma gian... | endpts.com... |
14.01.2020 | Daily funding roundup - January 14th, 2020 | SurvivorNet, Nicoya, Containous and Lemongrass Consulting raised 10M
Spotio: Spotio is a mobile sale... | vator.tv/n... |
14.01.2020 | AbSci Raises $15.4M in Series D Funding | AbSci, a Vancouver, Wash.-based protein printing company, closed a $10.4M Series D financing.
The ro... | finsmes.co... |
13.01.2020 | AbSci secures $15.4M Series D funding to accelerate growth a... | AbSci, a biopharma startup and developer of cutting-edge protein production technologies, has closed... | techstartu... |
13.01.2020 | AbSci closes $15.4 M in Series D funding to accelerate growt... | - | colventure... |
20.06.2018 | AbSci aims to tackle the antibody market after raising $12m ... | - | colventure... |
30.05.2018 | AbSci raises oversubscribed $12M Series C to fuel commercial... | - | colventure... |
30.05.2018 | Biomanufacturing company AbSci raises $12M to scale syntheti... | - | colventure... |
30.05.2018 | Vancouver-based AbSci raises $12 million for research produc... | - | colventure... |
30.05.2018 | Protein Expression Platform Developer AbSci Raises $12M in S... | AbSci, a Vancouver, Wash.-based developer of biomanufacturing technologies, completed a $12m Series ... | finsmes.co... |
30.05.2018 | Biomanufacturing company AbSci raises $12M to scale syntheti... | AbSci CEO and Founder Sean McClain. (AbSci Photo)
Vancouver, Wash.,-based biotechnology company AbSc... | geekwire.c... |
25.04.2016 | AbSci Secures $5.1M in Series A Financing | AbSci, a Portland, Oregon-based provider of soluble microbial protein expression technology, secured... | finsmes.co... |